{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/100-1835946(active).pdf"}, "page_content": "1 B 6 4 9\n\n5 3 8 1 P E\n\nEuropaisches Patentamt European Qrtic europ\u00e9en\n\n(19)\n\n(11) EP 1 835 946 B1\n\n(12)\n\nEUROPEAN PATENT SPECIFICATION\n\n(45) Date of publication and mention of the grant of the patent: 27.10.2010 Bulletin 2010/43\n\n(51)\n\nInt Cl.: A61L27/04(2006.01)\n\nAG1L 27/04 (2006.01) C23C 14/48 (2006.01)\n\n(21) Application number: 06704680.5\n\n(86)\n\nInternational application number: PCT/CN2006/000038\n\n(22) Date of filing: 11.01.2006\n\n(87)\n\nInternational publication number: WO 2006/074604 (20.07.2006 Gazette 2006/29)\n\n(54) SURFACE TREATED SHAPE MEMORY MATERIALS AND METHODS FOR MAKING SAME\n\nOBERFL\u00c4CHENBEHANDELTE FORMSPEICHERMATERIALIEN UND HERSTELLUNGSVERFAHREN DAF\u00dcR\n\nMATERIAUX A MEMOIRE DE FORME TRAITES EN SURFACE ET PROCEDE DE PRODUCTION ASSOCIES\n\n(84) Designated Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR\n\n(74) Representative: Barth, Stephan Manuel et al\n\nReinhard, Skuhra, Weise & Partner GbR Patent- und Rechtsanw\u00e4lte Friedrichstrasse 31 80801 M\u00fcnchen (DE)\n\n(30) Priority: 13.01.2005 US 643744 P\n\n(56) References cited:\n\n(43) Date of publication of application: 26.09.2007 Bulletin 2007/39\n\nWO-A-2004/108983 WO-A1-01/48262 CN-A- 1 150 180 US-A- 5 674 293\n\nDE-A1- 10 309 019\n\n(73) Proprietors:\n\n\u2022 Versitech Limited\n\nHong Kong, Special Administrive Region (CN)\n\n\u2022 City University of Hong Kong Hong Kong (CN)\n\nR.W.Y. POON ET AL: \"Carbon plasma immersion\n\nion implantation of nickel-titanium shape memory alloys\" BIOMATERIALS, vol. 26, 2005, pages 2265-2272, XP002460309\n\n(72) Inventors:\n\n\u2022 YEUNG, W. K. Kelvin\n\nNew Territories, Hong Kong (CN) \u2022 POON, W. Y. R.,\n\nPOON, W. Y. R., Rm. 408, 4/F, Block East Kowloon, Hong Kong (CN)\n\nRm. 408, 4/F, Block East Kowloon, Hong Kong (CN) \u2022 CHU, Kimho Paul,\n\n4A Village Gardens Kowloon, Hong Kong (CN)\n\n\u2022 CHEUNG, M. C. Kenneth, 27B Visalia Garden Mid-Levels, Hong Kong (CN)\n\n\u2022 LU, W., William\n\nHong Kong (CN)\n\n\u2022 S. M\u00c4NDL ET AL: \"Investigation on plasma immersion ion implantation treated medical implants\" BIOMOLECULAR ENGINEERING, vol. 19, 2002, pages 129-132, XP002460310\n\n\u2022 L. TAN ET AL: \"Corrosion and wear-corrosion behavior of Niti modified by plasma source ion implantation\" BIOMATERIALS, vol. 24, 2003, pages 3931-3939, XP002460312\n\n\u2022 L. TAN ET AL: \"Surface characterization of NiTi modified by plasma source ion implantation\" ACTA MATERIALIA, vol. 50, 2002, pages 4449-4460, XP002460313\n\nimmersions-ionenimplantation. Ein neues Verfahren zum homogenen Oberfl\u00e4chenmodifizierung komplex geformter medizinischer Implantate.\" BIOMEDIZINISCHE TECHNIK, vol. 45, no. 7-8, 2000, pages 193-198, XP008086286\n\nNote: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).\n\nPrinted by Jouve, 75001 PARIS (FR)\n\n(Cont. next page)\n\nEP 1 835 946 B1\n\n\u2022 SHABALOVSKAYA S A: \"Surface, corrosion and biocompatibility aspects of Nitinol as an implant material\" BIO-MEDICAL MATERIALS AND ENGINEERING, IOS PRESS, AMSTERDAM,, NL, vol. 12, no. 1, 2002, pages 69-109, XP002331496 ISSN: 0959-2989\n\n|\n\nRemarks:\n\nThe file contains technical information submitted after the application was filed and not included in this specification\n\n\u2022 A. ANDERS: \"Metal plasma immersion ion implantation and deposition: a review.\" SURFACE AND COATINGS TECHNOLOGY, vol. 93, 1997, pages 158-167, XP002460328\n\n2\n\n5\n\n10\n\n15\n\n20\n\n25\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\nEP 1 835 946 B1\n\nDescription\n\nBACKGROUND OF THE INVENTION\n\n[0001] Shape memory materials such as nickel titanium (NiTi) alloys are promising materials for surgical implants in orthopedics due to their unique shape memory effect (SME) and super-elasticity (SE) that other common orthopedic materials such as stainless steels and titanium alloys do not possess. Their mechanical properties are also closer to that of cortical bones than stainless steels and titanium alloys. The materials display superior wear resistance to CoCrMo alloys used in bone trauma fixation. Several other favorable properties of the materials have also been investigated, and good bio-compatibility has also been reported. However, some negative effects have also been pointed out. For example, Berger-Gorbet et al. have found that the osteogenesis process and osteonectin synthesis activity in NiTi alloys are unfavorable compared to stainless steels and titanium alloys.1 Jia et al. in their study revealed that the cell death rate was severe on NiTi alloys.2 [0002] These problems are believed to stem from the poor corrosion resistance of the materials, which may lead to an increase in their cytotoxicity. It is most likely that some toxic components released from the substrate cause the cell death rather than the apoptosis.3 Shih et al. reported that the supernatant and corrosive products from NiTi may result in the death of smooth muscle cells, especially when the amount of released nickel is higher than 9 ppm.4 A few other studies have also reported that nickel ions 5,6 leached from the alloys cause allergic reactions in nickel hypersensitive patients.7-10 While the homogeneity of the materials microstructures and the surface morphology may alter the anti- corrosion ability of NiTi alloys, there is no doubt that the corrosion resistance and anti-wear properties of the materials must be enhanced before the materials can be widely used clinically, especially as orthopedic implants with couplings where fretting is expected. [0003] Titanium carbides and nitrides have excellent mechanical and chemical properties, for example, good wear resistance, inactive with numbers of chemical substances and outstanding hardness [11-16]. Titanium oxides are known to be fairy compatible with living tissues [17-20]. They are also inactive to many chemical reactions. In surface coating industries, these elements have been applied to improve the mechanical and corrosion properties of the substrates through various methods [21-25] for a period of time.\n\nSUMMARY OF THE INVENTION\n\n[0004] The invention provides a method for the altering surface composition of a nickel titanium alloy part to increase biocompatibility, comprising implanting nitrogen or oxygen on the surface of the nickel titanium alloy part by plasma immersion ion implantation and deposition or related ion-beam and plasma-based techniques such as plasma-enhanced vapor phase deposition (PECVD), physical vapor deposition (VPD), and chemical vapor deposition (CVD), wherein the energy of the incident specimen used for surface treatment of the material ranges from 500 eV to 100 keV for plasma immersion ion implantation and deposition. [0005] The invention also provides orthopedic, vascular, and esophageal implants made from the foregoing materials.\n\nBRIEF DESCRIPTION OF THE DRAWINGS\n\n[0006]\n\nFIG. 1 is a plot of Ni depth profiles acquired from the nitrogen, acetylene and oxygen PIII surface treated samples and control. FIG. 2 includes photomicrographs of treated and untreated NiTi (control) after two days of cell culturing showing the EGFP expressing mouse osteoblasts. (A) NiTi alloy without surface treatment, (B) with nitrogen PIII implantation, (C) with acetylene PIII implantation, and (D) with oxygen PIII implantation.\n\nDETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION\n\n[0007] Shape memory materials such as nickel titanium alloys (NiTi) are useful materials in biomedical applications due to their unique properties. However, for prolonged use in a human body, deterioration of the corrosion resistance of the materials becomes a critical issue, because of the possibility of deleterious ions released from the substrate to living tissues. Therefore, we suggested the use of plasma immersion ion implantation and deposition and related ion- beam and plasma-based techniques to implant some other elements, such as C2H2, N2, and O2, into NiTi substrates to alter corrosion resistance and wear properties of the alloys. We have successfully demonstrated that the corrosion resistance and wear properties of nickel titanium shape memory alloys can be enhanced by implanting nitrogen, carbon and oxygen onto the substrate surface. Additionally, with the use of plasma immersion ion implantation or deposition,\n\n3\n\n5\n\n10\n\n15\n\n20\n\n25\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\n55\n\nEP 1 835 946 B1\n\nthe biological properties such as osteoconductivity and hydrophilicity can also be reduced or enhanced. [0008] The invention provides a method for the altering surface composition of a nickel titanium alloy part to increase biocompatibility, comprising implanting nitrogen or oxygen on the surface of the nickel titanium alloy part by plasma immersion ion implantation and deposition, wherein the energy of the incident specimen used for surface treatment ranges from 500 eV to 100 keV for plasma immersion ion implantation and deposition. The nickel titanium alloy is preferably a shape memory alloy, and has a nickel content ranging from about 20-80% of nickel and 80-20% of titanium. The surface implantation of elements enhances the mechanical properties of the alloy, such as hydrophilicity, corrosion and wear resistance. The nickel titanium alloy part can be reduced or enhanced. In practicing the invention, the plasma immersion ion implantation and deposition or related ion-beam and plasma-based techniques such as plasma-enhanced vapor phase deposition (PECVD), physical vapor deposition (VPD), and chemical vapor deposition (CVD) can reduce, terminate or prevent the deleterious ions from being released from the substrate of the shape memory materials. The materials may be biomaterials used for orthopedics, urologics, vascular surgery, hepatobiliary surgery or esophageal surgery. The energy of the incident species used for surface treatment of the materials ranges from 500 eV to 100 keV for implantation and deposition. Preferably, the energy of the surface treatment of the materials ranges from 500 eV to 1000eV for implantation and deposition. The direct current is applied with the parameters 0 Hz repetition with \u2019infinite\u2019 pulse duration to 5000 Hz. The material implanted is a nitrogen source, a carbon source, or an oxygen source, gaseous, liquid, or solid form. The nitrogen source is nitrogen gas. The carbon source is acetylene or a derivative thereof. The oxygen source is oxygen gas. [0009] The method may be used to make an orthopedic, vascular, or esophageal implant. [0010] For the purposes of promoting an understanding of the principles of the plasma immersion ion implantation and deposition or related ion-beam and plasma-based techniques such as plasma-enhanced vapor phase deposition (PECVD), physical vapor deposition (VPD), and chemical vapor deposition (CVD) on the surface of shape memory materials such as Ti - 50.8% at Ni alloy, the specific preferred embodiments of the invention will be described. [0011] Figure 1 indicates the Ni concentration profiles of the samples with and without PIII surface treatment. The Ni concentrations in the implanted region in nitrogen, acetylene and oxygen plasma-implanted samples are much lower when compared to the non-coated control sample. Nitrogen PIII gives rise to the highest Ni suppression compared to oxygen PIII. [0012] The treatment methods for acetylene, nitrogen and oxygen implantation the sample were ground, polished to a shiny surface texture, and then ultrasonically cleaned with acetone and ethanol before deposition or implantation was conducted in the plasma immersion ion implanter. The deposition and implantation parameters of acetylene, nitrogen and oxygen implantation samples were displayed in Table 1. The elemental depth profiles as shown in Figure 1 were determined by X-ray photoelectron spectroscopy (XPS) (Physical Electronics PHI 5802, Minnesota, USA).\n\nTable 1 -- Treatment parameters of plasma immersion ion implantation and deposition\n\nNiTi with NiTi with NiTi with acetylene nitrogen oxygen Sample implantation implantation implantation Gas type CoH, No Oo RF - 1000W 1000W High voltage -40kV -40kV -40kV Pulse width 30hs 50us 50us Frequency 200Hz 200Hz 200Hz Duration ofimplantation (min) 90 240 240 Base pressure 1x10-5Torr 7.0x10-6Torr 7.0x10-6Torr Working pressure 2.0x10-3Torr 6.4x10-4Torr 6.4x10-4Torr Dose 5.5x1016cm-2 9.6x1016cm-2 1.0x1017cm-2 Annealing pressure 1.0x10-5Torr 8.0x10-6Torr 8.0x10-6Torr Annealing temperature (\u00b0C) 600 450 450 Duration of annealing (h) 5 5 5\n\nNano-indentation tests (MTS Nano Indenter XP, USA) were conducted on five areas to determine the average hardness and Young\u2019s modulus of the treated and control samples. The hardness of the control sample is 4.5GPa and the Young\u2019s modulus is 57GPa. [0013] Table 2 lists the results of the hardness (H) and Young\u2019s modulus (E) of the untreated control and treated samples surfaces using nano-indentation test.\n\n4\n\n5\n\n10\n\n15\n\n20\n\n25\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\nEP 1 835 946 B1\n\nTable 2 -- Young\u2019s modulus and hardness of control and the treated samples surfaces\n\nSample NiTi NiTi implanted with acetylene NiTi implanted with nitrogen NiTi implanted with oxygen Young\u2019s modulus (GPa) Hardness (GPa) 57 4.5 110 - 70 9.5 - 4.5 150 - 65 11 - 5 115 - 60 8 - 4\n\nAll the surface-treated samples possess higher surface hardness and Young\u2019s modulus than those of the control. It implies that the treated surfaces are mechanically stronger than the NiTi substrates underneath and can withstand mechanical shock more effectively. Among the treated surfaces, the nitrogen-implanted layer has the largest. H and E, followed by the acetylene- and oxygen-implanted layers. [0014] Table 3 lists the amounts of Ni leached from the surface-treated and untreated samples after the electrochemical tests as determined by inductively coupled plasma mass spectrometry (ICPMS). Electrochemical tests based on ASTM G5-94 (1999) and G61-86 (1998) were performed by a potentiostat (VersaStat II EG&G, USA) using a standard simulated body fluid (SBF) at a pH of 7.42 and temperature of 3770.5 1 C (37.5\u00b0C). The ion concentrations in the SBF are shown in Table 4. A cyclic potential spanning between -400 and +1600mV was applied at a scanning rate of 600 mV/h. Before the electrochemical tests, the medium was purged with nitrogen for 1 h to remove dissolved oxygen and nitrogen purging continued throughout the measurements. The SBF taken from each sample after the corrosion test was analyzed for Ni and Ti employing inductively coupled plasma mass spectrometry (ICPMS) (Perkin Elmer, PE SCIEX ELAN6100, USA). The amounts of Ni leached from all treated samples were significantly reduced. The magnitudes were only about 0.03 to 0.04% of that of the control samples. The ion concentrations in the SBF are shown in Table 4.\n\nTable 3 -- Amounts of Ni and Ti ions detected in SBF by ICPMS after electrochemical tests\n\nSample Ni content (ppm) Ti content (ppm)\n\nTable 4 -- Ion concentration of SBF solution\n\nConcentration (mM) Na+ K+ Ca2+ Mg2+ - HCO3 Cl- HPO4 2- SO4 142.0 5.0 2.5 1.5 4.2 148.5 1.0 0.5\n\n2-\n\n[0015] Figure 2 demonstrates that the nitrogen, acetylene and oxygen plasma-implanted samples are well tolerated by the EGFP-expressing osteoblasts. The osteoblasts were isolated from calvarial bones of 2-day-old mice that ubiqui- tously express an enhanced green fluorescent protein (EGFP) were used to culture in a Dulbecco\u2019s Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (Biowest, France), antibiotics (100 U/ml of penicillin and 100 Pg/ml of streptomycin), and 2mM L-glutamine at 37\u00b0C in an atmosphere of 5% CO2 and 95% air. The specimens (1 mm thick and 5 mm in diameter) were fixed onto the bottom of a 24-well tissue culture plate (Falcon) using 1% (w/v) agarose. A cell suspension of 5,000 cells was seeded onto the surface of the untreated NiTi samples and the three types of plasma-implanted samples (oxygen, nitrogen, and acetylene). Cells were grown in one ml of medium and changed every two days. Cell attachment and proliferation were examined after the second day of culture. After culturing for two days, the cells started to attach to and proliferate on all the samples. Our results unequivocally demonstrate that there is no immediate cytotoxic effect on all of the surface treated samples. [0016] It should be apparent to a person of ordinary skill that the improved alloys obtainable with the present invention can be used for a wide variety of applications, both as biomaterials and for other applications where such alloys might prove advantageous. For example, the alloys may be used to fashion orthopedic implants including replacement joints such as hips, knees, shoulders, elbows, fingers, or for rods, screws, nails, spinal implants and the like used for orthopedic purposes. They may also be used to form thin matches useful for making patches, tubing, and devices useful in urologic, cardiac, spinal, cerebrospinal, gastrointestinal, hepatobiliary, vascular, or esophageal surgery.\n\n5\n\n5\n\n10\n\n15\n\n20\n\n25\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\nEP 1 835 946 B1\n\nREFERENCES CITED\n\n[0017]\n\n1. Berger-Gorbet, M., et al., \"Biocompatibility Testing of NiTi Screws Using Immunohistochemistry on Sections Containing Metallic Implants,\" Journal of Biomedical Materials Research, 1996;32(2):243-8. 2. Jia, W., et al., \"Nickel Release from Orthodontic Arch Wires and Cellular Immune Response to Various Nickel Concentrations,\" Journal of Biomedical Materials Research, 1999; 48(4):488-95. 3. Es-Souni M., et al., \"On the Properties of Two Binary NiTi Shape Memory Alloys: Effects of Surface Finish on the Corrosion Behavior and In Vitro Biocompatibility,\" Biomaterials, 2002; 23(14):2887-2894. 4. Shih, C-C., et al., \"The Cytotoxicity of Corrosion Products of Nitinol Stent Wire on Cultured Smooth Muscle Cells,\" Journal of Biomedical Materials Research, 2000; 52(2):395-403. 5. Kapanen, A., et al., \"Behavior of Nitinol in Osteoblast-like ROS-17 Cell Cultures,\" Biomaterials, 2002;23(3): 645-650. 6. Kapanen, A., et al., \"TGF-[beta]1 Secretion of ROS-17/2.8 Cultures on NiTi Implant Material,\" Biomaterials, 2002; 23(16):3341-3346. 7. Dalmau, L.B., et al., \"A Study of Nickel Allergy,\" Journal of Prosthet. Dent. 1984; 52:116-119. 8. Lamster, I.B., et al., \"Rapid Loss of Alveolar Bone Associated with Nonprecious Alloy Crowns in Two Patients with Nickel Hypersensitivity,\" Journal of Periodont. 1987; 58:486-492. 9. Espana, A., et al., \"Chronic Urticaria After Implantation of 2 Nickel-Containing Dental Prostheses in a Nickel- Allergic Patient,\" Contact Dermat. 1989; 21:204-206. 10. Sanford, W.E. and Niboer, E., \"Renal Toxicity of Nickel in Humans,\" Nriagu JO, ed. Nickel and Human Health Current Perspectives, Canada: John Wiley & Sons, Inc.; 1992. p123-134. 11. Wu, S.K., et al., \"A Study of Vacuum Carburization of an Equiatomic TiNi Shape Memory Alloy,\" Scripta Materialia 1997; 37:837-842. 12. Huber, P., et al., \"Formation of TiN, TiC and TiCN by Metal Plasma Immersion Ion Implantation and Deposition,\" Surface and Coatings Technology 2003; 174-175:1243-1247. 13. Liu, N., et al., \"Effect of Nano-Micro TiN Addition on the Microstructure and Mechanical Properties of TiC Based Cermets,\" Journal of the European Ceramic Society 2002; 22:2409-2414. 14. Oliveira, M.M. and Bolton, J.D., \"High-Speed Steels: Increasing Wear Resistance by Adding Ceramic Particles,\" Journal of Materials Processing Technology 1999; 92-93:15-20. 15. Vaz, F., et al., \"Structural, Optical and Mechanical Properties of Coloured TiNxOy Thin Films,\" Thin Solid Films 2004; 447-448:449-454. 16. Kola, P.V., et al., \"Magnetron Sputtering of Tin Protective Coatings for Medical Applications,\" Journal of Materials Processing Technology 1996; 56:422-430. 17. Tan, L. and Crone, W.C., \"Surface Characterization of NiTi Modified by Plasma Source Ion Implantation,\" Acta Materialia 2002; 50:4449-4460. 18. M\u00e4ndl, S., et al., \"Investigation on Plasma Immersion Ion Implantation Treated Medical Implants,\" Biomolecular Engineering 2002;19:129-132. 19. Nie, X., et al., \"Deposition of Layered Bioceramic Hydroxyapatite/TiO2 Coatings on Titanium Alloys Using a Hybrid Technique of Micro-Arc Oxidation and Electrophoresis,\" Surface and Coatings Technology 2000; 125: 407-414. 20. Lackner, J.M., et al., \"Pulsed Laser Deposition of Titanium Oxide Coatings at Room Temperature-Structural, Mechanical and Tribological Properties,\" Surface and Coatings Technology 2004;180-181:585-590. 21. Li, M.C., et al., \"Corrosion Behavior of TiN Coated Type 316 Stainless Steel in Simulated PEMFC Environments,\" Corrosion Science 2004; 46:1369-1380. 22. Wan, G.J., Huang et al., \"TiN and Ti-O/TiN Films Fabricated by PIII-D for Enhancement of Corrosion and Wear Resistance of Ti-6Al-4V,\" Surface and Coatings Technology 2004, In Press. 23. Pfohl, C., et al., \"Evaluation of the Corrosion Behaviour of Wear-Resistant PACVD Coatings,\" Surface and Coatings Technology 1999; 112:114-117. 24. Maiya, P.S., et al., \"Failure and Corrosion Resistance of TiN and TiC Coatings Deposited on Graphite by Chemical Vapor Deposition,\" Surface and Coatings Technology 1998; 102:218-222. 25. Leng, Y.X., et al., \"Structure and Properties of Biomedical TiO2 Films Synthesized by Dual Plasma Deposition,\" Surface and Coatings Technology 2002; 156:295-300.\n\n6\n\nEP 1 835 946 B1\n\nClaims\n\n5\n\n1. A method for the altering surface composition of a nickel titanium alloy part to increase biocompatibility, comprising implanting nitrogen or oxygen on the surface of the nickel titanium alloy part by plasma immersion ion implantation and deposition, wherein the energy of the incident species used for surface treatment of the materials ranges from 500 eV to 100 keV for plasma immersion ion implantation and deposition.\n\n10\n\n2. The method according to claim 1, wherein the nickel titanium alloy is a shape memory alloy, and has a nickel content ranging from 20-80% of nickel and 80-20% of titanium.\n\n3. A method according to claim 1, wherein the surface implantation of elements enhances the mechanical properties of the alloy.\n\n15\n\n4. A method according to claim 3, wherein the surface mechanical properties include hydrophilicity, corrosion and wear resistance.\n\n5. A method according to claim 2, wherein the bioactivity of the nickel titanium alloy is reduced or enhanced.\n\n20\n\n6. A method according to claim 2, wherein the plasma immersion ion implantation and deposition or related ion-beam and plasma-based techniques such as plasma-enhanced vapour phase deposition (PECVD), physical vapour dep- osition (VPD), and chemical vapour deposition (CVD) reduce the Ni ions released from the substrate of the shape memory materials.\n\n25\n\n7. A method according to claim 2, wherein the materials are biomaterials used for orthopedics, urologics, vascular surgery, hepatobiliary surgery or esophageal surgery.\n\n8. A method according to claim 6, wherein the energy of the incident species used for surface treatment of the materials ranges from 500 eV to 1000 eV for implantation and deposition.\n\n30\n\n9. A method according to claim 6, wherein direct current is applied with the parameters 0 Hz repetition with infinite pulse duration to 5000 Hz.\n\n10. A method in accordance with claim 2, wherein the material implanted is a nitrogen source or an oxygen source.\n\n35\n\n11. A method in accordance with claim 10, wherein the nitrogen source is nitrogen gas.\n\n12. A method in accordance with claim 10, wherein the oxygen source is oxygen gas.\n\n40\n\n13. An orthopaedic implant made in accordance with the method of claim 1.\n\n14. A vascular implant made in accordance with the method of claim 1.\n\n15. An esophageal implant made in accordance with the method of claim 1.\n\n45\n\n16. A method according to claim 9, wherein the elements are in gas form liquid form, solid form, or composition thereof.\n\nPatentanspr\u00fcche\n\n50\n\n55\n\n1. Verfahren zum \u00c4ndern der Oberfl\u00e4chenzusammensetzung eines Nickel-Titan-Legierungsteils zum Erh\u00f6hen der Biokompatibilit\u00e4t mit dem Schritt des Implantierens von Stickstoff oder Sauerstoff auf der Oberfl\u00e4che des Nickel- Titan-Legierungsteils durch Plasmaimmersions-Ionenimplantation und -deposition, wobei die Energie der einfallen- den Spezies, welche zur Oberfl\u00e4chenbehandlung der Materialien verwendet wird, im Bereich von 500 eV bis 1000 keV f\u00fcr die Plasmaimmersions-Ionenimplantation und -deposition liegt.\n\n2. Verfahren nach Anspruch 1, wobei die Nickel-Titan-Legierung eine Formged\u00e4chtnislegierung ist und einen Nickel- gehalt im Bereich von 20-80 % an Nickel und 80-20 % von Titan aufweist.\n\n7\n\n5\n\n10\n\n15\n\n20\n\n25\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\nEP 1 835 946 B1\n\n3. Verfahren nach Anspruch 1, wobei die Oberfl\u00e4chenimplantation der Elemente die mechanischen Eigenschaften der\n\nLegierung verbessert.\n\n4. Verfahren nach Anspruch 3, wobei die mechanischen Oberfl\u00e4cheneigenschaften Hydrophilie, Korrosions- und Ver-\n\nschlei\u00dfwiderstand beinhalten.\n\n5. Verfahren nach Anspruch 2, wobei die Bioaktivit\u00e4t der Nickel-Titan-Legierung reduziert oder erh\u00f6ht wird.\n\n6. Verfahren nach Anspruch 2, wobei die Plasmaimmersions-Ionenimplantation und - deposition oder verwandte Io- nenstrahl- und plasmabasierte Techniken, wie zum Beispiel plasmaverst\u00e4rkte Dampfphasenabscheidung (PECVD), physikalische Dampfphasenabscheidungen (VPD) und chemische Dampfhasenabscheidungen (CVD) die Nicke- lionen reduzieren, welche von der Oberfl\u00e4che der Formged\u00e4chtnismaterialien gel\u00f6st werden.\n\n7. Verfahren nach Anspruch 2, wobei die Materialien Biomaterialien sind, welche f\u00fcr Orthop\u00e4die, Urologie, Gef\u00e4\u00dfchirugie, Hepatobili\u00e4r-Chriugie oder f\u00fcr \u00d6sophageal-Chirugie verwendet werden.\n\n8. Verfahren nach Anspruch 6, wobei die Energie der einfallenden Spezies, welche f\u00fcr die Oberfl\u00e4chenbehandlung der Materialien verwendet wird im Bereich von 500 eV bis 1.000 eV f\u00fcr die Implantation und Abscheidung liegt.\n\n9. Verfahren nach Anspruch 6, wobei ein Gleichstrom mit den Parametern 0 Hz Wiederholungsrate mit einer unbe- grenzten Pulsdauer bis zu 5000 Hz angelegt wird.\n\n10. Verfahren nach Anspruch 2, wobei das implantierte Material eine Stickstoffquelle oder eine Sauerstoffquelle ist.\n\n11. Verfahren nach Anspruch 10, wobei die Stickstoffquelle Stickstoffgas ist.\n\n12. Verfahren nach Anspruch 10, wobei die Sauerstoffquelle Sauerstoffgas ist.\n\n13. Orthop\u00e4disches Implantat hergestellt in \u00dcbereinstimmung mit dem Verfahren nach Anspruch 1.\n\n14. Gef\u00e4\u00dfimplantat hergestellt nach dem Verfahren gem\u00e4\u00df Anspruch 1.\n\n15. \u00d6sophageales Implantat hergestellt nach dem Verfahren gem\u00e4\u00df Anspruch 1.\n\n16. Verfahren nach Anspruch 9, wobei die Elemente in Gasform, Fl\u00fcssigform, Festform oder einer Zusammensetzung davon sind.\n\nRevendications\n\n1. Proc\u00e9d\u00e9 pour la composition de surface changeante d\u2019un \u00e9l\u00e9ment d\u2019alliage de nickel titane pour augmenter la biocompatibilit\u00e9, comprenant l\u2019implantation d\u2019azote ou d\u2019oxyg\u00e8ne sur la surface de l\u2019\u00e9l\u00e9ment d\u2019alliage de nickel titane par implantation et d\u00e9p\u00f4t d\u2019ions par immersion dans un plasma, dans lequel l\u2019\u00e9nergie de l\u2019esp\u00e8ce incidente utilis\u00e9e pour le traitement de surface des mati\u00e8res s\u2019\u00e9tend de 500 eV \u00e0 100 keV pour l\u2019implantation et le d\u00e9p\u00f4t d\u2019ions par immersion dans un plasma.\n\n2. Proc\u00e9d\u00e9 selon la revendication 1, dans lequel l\u2019alliage de nickel titane est un alliage \u00e0 m\u00e9moire de forme, et a une teneur en nickel allant de 20 \u00e0 80 % de nickel et de 80 \u00e0 20 % de titane.\n\n3. Proc\u00e9d\u00e9 selon la revendication 1, dans lequel l\u2019implantation de surface d\u2019\u00e9l\u00e9ments am\u00e9liore les propri\u00e9t\u00e9s m\u00e9ca-\n\nniques de l\u2019alliage.\n\n4. Proc\u00e9d\u00e9 selon la revendication 3, dans lequel les propri\u00e9t\u00e9s m\u00e9caniques de surface incluent le caract\u00e8re hydrophile, la r\u00e9sistance \u00e0 la corrosion et \u00e0 l\u2019usure.\n\n5. Proc\u00e9d\u00e9 selon la revendication 2, dans lequel la bioactivit\u00e9 de l\u2019alliage de nickel titane est r\u00e9duite ou am\u00e9lior\u00e9e.\n\n6. Proc\u00e9d\u00e9 selon la revendication 2, dans lequel l\u2019implantation et le d\u00e9p\u00f4t d\u2019ions par immersion dans un plasma ou\n\n8\n\nEP 1 835 946 B1\n\ndes techniques li\u00e9es \u00e0 base de plasma et de faisceau d\u2019ions comme le d\u00e9p\u00f4t en phase vapeur am\u00e9lior\u00e9 au plasma (PECVD), le d\u00e9p\u00f4t physique en phase vapeur (VPD) et le d\u00e9p\u00f4t chimique en phase vapeur (CVD) r\u00e9duisent les ions Ni lib\u00e9r\u00e9s provenant du substrat des mati\u00e8res \u00e0 m\u00e9moire de forme.\n\n5\n\n7. Proc\u00e9d\u00e9 selon la revendication 2, dans lequel les mati\u00e8res sont des biomat\u00e9riaux utilis\u00e9s pour l\u2019orthop\u00e9die, l\u2019urologie, la chirurgie vasculaire, la chirurgie h\u00e9patobiliaire ou la chirurgie oesophagienne.\n\n8. Proc\u00e9d\u00e9 selon la revendication 6, dans lequel l\u2019\u00e9nergie de l\u2019esp\u00e8ce incidente utilis\u00e9e pour le traitement de surface des mati\u00e8res s\u2019\u00e9tend de 500 eV \u00e0 1 000 eV pour l\u2019implantation et le d\u00e9p\u00f4t.\n\n10\n\n9. Proc\u00e9d\u00e9 selon la revendication 6, dans lequel un courant continu est appliqu\u00e9 avec les param\u00e8tres de r\u00e9p\u00e9tition de 0 Hz avec une dur\u00e9e d\u2019impulsion infinie \u00e0 5 000 Hz.\n\n10. Proc\u00e9d\u00e9 selon la revendication 2, dans lequel la mati\u00e8re implant\u00e9e est une source d\u2019azote ou une source d\u2019oxyg\u00e8ne.\n\n15\n\n11. Proc\u00e9d\u00e9 selon la revendication 10, dans lequel la source d\u2019azote est un gaz d\u2019azote.\n\n12. Proc\u00e9d\u00e9 selon la revendication 10, dans lequel la source d\u2019oxyg\u00e8ne est un gaz d\u2019oxyg\u00e8ne.\n\n13. Implant orthop\u00e9dique r\u00e9alis\u00e9 selon le proc\u00e9d\u00e9 de la revendication 1.\n\n14. Implant vasculaire r\u00e9alis\u00e9 selon le proc\u00e9d\u00e9 de la revendication 1.\n\n15. Implant oesophagien r\u00e9alis\u00e9 selon le proc\u00e9d\u00e9 de la revendication 1.\n\n25\n\n16. Proc\u00e9d\u00e9 selon la revendication 9, dans lequel les \u00e9l\u00e9ments sont sous forme de gaz, sous forme de liquide, sous forme de solide, ou une composition de ceux-ci.\n\n30\n\n35\n\n40\n\n45\n\n50\n\n55\n\n9\n\nEP 1 835 946 B1\n\nAtomic concentration (%) \u2014?\u2014N-implanted ~a--C-implanted ++ @-- O-implanted \u4e8c \u5174 - Control 0 50 100 150 200 Depth (nm) FIG. 1\n\n10\n\nEP 1 835 946 B1\n\n11\n\nEP 1 835 946 B1\n\nREFERENCES CITED IN THE DESCRIPTION\n\nThis list of references cited by the applicant is for the reader\u2019s convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.\n\nNon-patent literature cited in the description\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBerger-Gorbet, M. et al. Biocompatibility Testing of NiTi Screws Using Immunohistochemistry on Sec- tions Containing Metallic Implants. Journal of Bio- medical Materials Research, 1996, vol. 32 (2), 243-8 [0017] Jia, W. et al. Nickel Release from Orthodontic Arch Wires and Cellular Immune Response to Various Nickel Concentrations. Journal of Biomedical Mate- rials Research, 1999, vol. 48 (4), 488-95 [0017] Es-Souni M. et al. On the Properties of Two Binary NiTi Shape Memory Alloys: Effects of Surface Finish on the Corrosion Behavior and In Vitro Biocompati- bility. Biomaterials, 2002, vol. 23 (14), 2887-2894 [0017] Shih, C-C. et al. The Cytotoxicity of Corrosion Prod- ucts of Nitinol Stent Wire on Cultured Smooth Muscle Cells. Journal of Biomedical Materials Research, 2000, vol. 52 (2), 395-403 [0017] Kapanen, A. et al. Behavior of Nitinol in Osteob- last-like ROS-17 Cell Cultures. Biomaterials, 2002, vol. 23 (3), 645-650 [0017] Kapanen, A. et al. TGF-[beta]1 Secretion of ROS-17/2.8 Cultures on NiTi Implant Material. Bio- materials, 2002, vol. 23 (16), 3341-3346 [0017] Dalmau, L.B. et al. A Study of Nickel Allergy. Journal of Prosthet. Dent., 1984, vol. 52, 116-119 [0017] Lamster, I.B. et al. Rapid Loss of Alveolar Bone As- sociated with Nonprecious Alloy Crowns in Two Pa- tients with Nickel Hypersensitivity. Journal of Perio- dont, 1987, vol. 58, 486-492 [0017] Espana, A. et al. Chronic Urticaria After Implantation of 2 Nickel-Containing Dental Prostheses in a Nick- el-Allergic Patient. Contact Dermat., 1989, vol. 21, 204-206 [0017] Renal Toxicity of Nickel in Humans. Sanford, W.E. ; Niboer, E. Nickel and Human Health Current Per- spectives. John Wiley & Sons, Inc, 1992, 123-134 [0017]\n\nOliveira, M.M. ; Bolton, J.D. High-Speed Steels: In- creasing Wear Resistance by Adding Ceramic Parti- cles. Journal of Materials Processing Technology, 1999, vol. 92-93, 15-20 [0017] Vaz, F. et al. Structural, Optical and Mechanical Properties of Coloured TiNxOy Thin Films. Thin Solid Films, 2004, vol. 447-448, 449-454 [0017] Kola, P.V. et al. Magnetron Sputtering of Tin Protec- tive Coatings for Medical Applications. Journal of Ma- terials Processing Technology, 1996, vol. 56, 422-430 [0017] Tan, L. ; Crone, W.C. Surface Characterization of NiTi Modified by Plasma Source Ion Implantation. Ac- ta Materialia, 2002, vol. 50, 4449-4460 [0017] \u2022 M\u00e4ndl, S. et al. Investigation on Plasma Immersion Ion Implantation Treated Medical Implants. Biomo- lecular Engineering, 2002, vol. 19, 129-132 [0017] Nie, X. et al. Deposition of Layered Bioceramic Hy- droxyapatite/TiO2 Coatings on Titanium Alloys Using a Hybrid Technique of Micro-Arc Oxidation and Elec- trophoresis. Surface and Coatings Technology, 2000, vol. 125, 407-414 [0017] Lackner, J.M. et al. Pulsed Laser Deposition of Ti- tanium Oxide Coatings at Room Temperature-Struc- tural, Mechanical and Tribological Properties. Sur- face and Coatings Technology, 2004, vol. 180-181, 585-590 [0017] Li, M.C. et al. Corrosion Behavior of TiN Coated Type 316 Stainless Steel in Simulated PEMFC Environ- ments. Corrosion Science, 2004, vol. 46, 1369-1380 [0017]\n\n\n\n\n\n\n\n\n\n\n\n\n\nWan, G.J., Huang et al. TiN and Ti-O/TiN Films Fab- ricated by PIII-D for Enhancement of Corrosion and Wear Resistance of Ti-6Al-4V. Surface and Coatings Technology, 2004 [0017] Pfohl, C. et al. Evaluation of the Corrosion Behaviour of Wear-Resistant PACVD Coatings. Surface and Coatings Technology, 1999, vol. 112, 114-117 [0017]\n\n\n\nWu, S.K. et al. A Study of Vacuum Carburization of an Equiatomic TiNi Shape Memory Alloy. Scripta Ma- terialia, 1997, vol. 37, 837-842 [0017] Huber, P. et al. Formation of TiN, TiC and TiCN by Metal Plasma Immersion Ion Implantation and Dep- osition. Surface and Coatings Technology, 2003, vol. 174-175, 1243-1247 [0017] Liu, N. et al. Effect of Nano-Micro TiN Addition on the Microstructure and Mechanical Properties of TiC Based Cermets. Journal of the European Ceramic Society, 2002, vol. 22, 2409-2414 [0017]\n\n\n\n\n\nMaiya, P.S. et al. Failure and Corrosion Resistance of TiN and TiC Coatings Deposited on Graphite by Chemical Vapor Deposition. Surface and Coatings Technology, 1998, vol. 102, 218-222 [0017] Leng, Y.X. et al. Structure and Properties of Biomed- ical TiO2 Films Synthesized by Dual Plasma Depo- sition. Surface and Coatings Technology, 2002, vol. 156, 295-300 [0017]\n\n\n\n12", "type": "Document"}}